TON - April 2023 Vol 16, No 2

I am pleased to present the April issue of The Oncology Nurse-APN/PA, a journal specifically designed for nurses, navigators, and advanced practice providers who work tirelessly to improve the lives of patients with cancer. Read More ›

The Nellie B. Connally Breast Center at The University of Texas MD Anderson Cancer Center, Houston, is among the largest in the country. MD Anderson’s team of breast cancer oncologists and subspecialists address all diagnoses, medical complications, and symptoms associated with the disease. Read More ›

An analysis from the ARASENS trial showed that the addition of darolutamide to androgen-deprivation therapy and docetaxel significantly improved overall survival in subgroups of patients with metastatic hormone-sensitive prostate cancer with high-volume and high-risk disease, contributing to the evidence that this combination should be considered the new standard of care for this patient population. Read More ›

Numerous changes need to be made to raise public awareness of the fact that drinking alcohol raises the risk for several types of cancer. Read More ›

Columbus, OH—Intentional modifications to diet are being investigated as a strategy to reduce chronic cancer-related fatigue, according to new data published in the journal Nutrition & Cancer by researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and The Ohio State University Wexner Medical Center. Read More ›

The FDA has issued a final rule intended to ensure patients are better informed about their breast tissue density when undergoing mammography. Read More ›

On January 25, 2023, the American Nurses Foundation (the Foundation) released the findings from a new comprehensive survey of more than 12,500 nurses nationwide as part of the Pulse on the Nation’s Nurses Survey Series. Read More ›

The decision to use adjuvant therapies in patients with renal-cell carcinoma (RCC) should be based on risk, patient goals, and shared decision-making. This topic was explored in a presentation by Matthew Zibelman, MD, Associate Professor, Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, at the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium. Read More ›

Young women with early-stage, hormone receptor–positive breast cancer attempting to become pregnant can safely pause endocrine therapy and resume it later, according to initial results from the international POSITIVE trial. Read More ›

A new report released by the American Cancer Society (ACS) shows that the incidence of colorectal cancer is rapidly increasing among younger individuals, and the disease is also being diagnosed at more advanced stages in people of all ages. Read More ›